Cargando…
Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection
INTRODUCTION: Data on willingness to participate in population-based long-COVID studies are sparse. We invited all citizens of Essen aged 18-74 years with a positive SARS-CoV-2 PCR test between Mar-Aug 2020 and assessed COVID-related symptoms in responders ∼1.5 years after infection. METHODS: The in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619969/ http://dx.doi.org/10.1093/eurpub/ckac131.051 |
_version_ | 1784821301083373568 |
---|---|
author | Schramm, S Wilk, L Kowall, B Jöckel, KH Stang, A Schmidt, B |
author_facet | Schramm, S Wilk, L Kowall, B Jöckel, KH Stang, A Schmidt, B |
author_sort | Schramm, S |
collection | PubMed |
description | INTRODUCTION: Data on willingness to participate in population-based long-COVID studies are sparse. We invited all citizens of Essen aged 18-74 years with a positive SARS-CoV-2 PCR test between Mar-Aug 2020 and assessed COVID-related symptoms in responders ∼1.5 years after infection. METHODS: The invited population included 1282 infected citizens (48% women). At the time of testing 64% reported symptoms. We asked responders about past and current symptoms, hospitalization, smoking, sport, pre-existing conditions (heart attack, stroke, diabetes), subjective health status as compared to before infection, assessed BMI, and performed descriptive statistics. RESULTS: We investigated 255 participants (50% women, 19-73 years, response rate 20%) ∼20 month (median) after the PCR test. 95% reported symptoms at the time of testing: 67% fatigue, 58% taste disorders, 56% limb pain, 55% odor disorders, 54% headache, 50% cough, 43% fever; 10% needed hospitalization, 3% intensive care, 1.6% artificial ventilation. Compared to the non-hospitalized the formerly inpatients were more often male (62% vs 49%), older (56±13 vs 49±14 years), less often never smokers (42% vs 53%), had a higher BMI (31±7 vs 28±5 kg/m(2)), and more pre-existing conditions (23% vs 10%). Compared to before infection, 53% rated their current health worse, with a higher rate among inpatients (81%). After ∼1.5 years, 55% still reported symptoms: 25% fatigue, 20% concentration disorder, 18% breathing problems, 13% odor and 11% taste disorders. Persistent symptoms were more common in inpatients than in non-hospitalized (69% vs 53%). CONCLUSIONS: Symptomatic individuals are more likely to participate in a COVID19 follow-up study than asymptomatic ones. This may overestimate the number of individuals with long-term symptoms in population-based long-COVID study populations. However, persistent symptoms seem to be more likely in formerly inpatients compared to non-hospitalized individuals with former SARS-CoV-2 infection. KEY MESSAGES: • Symptomatic individuals are more likely to participate in a COVID19 follow-up study than asymptomatic ones. • Persistent symptoms seem to be more likely in formerly inpatients compared to non-hospitalized individuals with former SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-9619969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96199692022-11-04 Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection Schramm, S Wilk, L Kowall, B Jöckel, KH Stang, A Schmidt, B Eur J Public Health Poster Displays INTRODUCTION: Data on willingness to participate in population-based long-COVID studies are sparse. We invited all citizens of Essen aged 18-74 years with a positive SARS-CoV-2 PCR test between Mar-Aug 2020 and assessed COVID-related symptoms in responders ∼1.5 years after infection. METHODS: The invited population included 1282 infected citizens (48% women). At the time of testing 64% reported symptoms. We asked responders about past and current symptoms, hospitalization, smoking, sport, pre-existing conditions (heart attack, stroke, diabetes), subjective health status as compared to before infection, assessed BMI, and performed descriptive statistics. RESULTS: We investigated 255 participants (50% women, 19-73 years, response rate 20%) ∼20 month (median) after the PCR test. 95% reported symptoms at the time of testing: 67% fatigue, 58% taste disorders, 56% limb pain, 55% odor disorders, 54% headache, 50% cough, 43% fever; 10% needed hospitalization, 3% intensive care, 1.6% artificial ventilation. Compared to the non-hospitalized the formerly inpatients were more often male (62% vs 49%), older (56±13 vs 49±14 years), less often never smokers (42% vs 53%), had a higher BMI (31±7 vs 28±5 kg/m(2)), and more pre-existing conditions (23% vs 10%). Compared to before infection, 53% rated their current health worse, with a higher rate among inpatients (81%). After ∼1.5 years, 55% still reported symptoms: 25% fatigue, 20% concentration disorder, 18% breathing problems, 13% odor and 11% taste disorders. Persistent symptoms were more common in inpatients than in non-hospitalized (69% vs 53%). CONCLUSIONS: Symptomatic individuals are more likely to participate in a COVID19 follow-up study than asymptomatic ones. This may overestimate the number of individuals with long-term symptoms in population-based long-COVID study populations. However, persistent symptoms seem to be more likely in formerly inpatients compared to non-hospitalized individuals with former SARS-CoV-2 infection. KEY MESSAGES: • Symptomatic individuals are more likely to participate in a COVID19 follow-up study than asymptomatic ones. • Persistent symptoms seem to be more likely in formerly inpatients compared to non-hospitalized individuals with former SARS-CoV-2 infection. Oxford University Press 2022-10-25 /pmc/articles/PMC9619969/ http://dx.doi.org/10.1093/eurpub/ckac131.051 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Displays Schramm, S Wilk, L Kowall, B Jöckel, KH Stang, A Schmidt, B Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection |
title | Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection |
title_full | Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection |
title_fullStr | Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection |
title_full_unstemmed | Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection |
title_short | Willingness to participate in a COVID-19 follow-up study and symptoms 1.5 years after infection |
title_sort | willingness to participate in a covid-19 follow-up study and symptoms 1.5 years after infection |
topic | Poster Displays |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619969/ http://dx.doi.org/10.1093/eurpub/ckac131.051 |
work_keys_str_mv | AT schramms willingnesstoparticipateinacovid19followupstudyandsymptoms15yearsafterinfection AT wilkl willingnesstoparticipateinacovid19followupstudyandsymptoms15yearsafterinfection AT kowallb willingnesstoparticipateinacovid19followupstudyandsymptoms15yearsafterinfection AT jockelkh willingnesstoparticipateinacovid19followupstudyandsymptoms15yearsafterinfection AT stanga willingnesstoparticipateinacovid19followupstudyandsymptoms15yearsafterinfection AT schmidtb willingnesstoparticipateinacovid19followupstudyandsymptoms15yearsafterinfection |